Bansal Wire Lists At 39% Premium, Emcure Pharma Gains 31% At Debut


Emcure Pharmaceuticals at Rs 1,325.05, a premium of 31.45 percent On the BSE. The initial public offer of steel wire manufacturer Bansal Wire Industries garnered 59.57 times subscriptions on the final day of bidding on July 5. The Rs 745-crore…
Originalartikel lesen: Bansal Wire Lists At 39% Premium, Emcure Pharma Gains 31% At Debut